Pfizer’s COVID–19 vaccine

Pfizer’s COVID–19 vaccine update

Third dose of Pfizer’s COVID – 19 vaccine within 12 months of getting fully inoculated could most likely prolong protection :

Pfizer’s CEO[1] Albert Bourla has recently made some speculations about Pfizer’s COVID–19 vaccine. He claimed that people might need a 3rd dose of the vaccine after getting fully inoculated. Per his claims, this is most likely to be administered within 12 months of inoculation. These were announced on 15 April 2021.

He further added that people would need to get vaccinated against coronavirus annually. He speculates that the third dose would be needed between six and 12 months of initial vaccination. However, all these are only mere speculations at the moment.

Read about

Bourla also stated that the sequence and the duration of protection offered by Pfizer’s COVID–19 vaccine are yet to be ascertained. As per his statements, the study revealed that the variants play a key role in the protection offered by the vaccine.

At the beginning of April 2021, Pfizer stated that its vaccine was over 91 % effective in protecting against coronavirus. It was also revealed to be around 95 % effective against severe COVID – 19 up to six months after the second dose.

This data was obtained based on the results of a study conducted on over 12,000 vaccinated participants. Several researchers are also working to reveal the duration of protection against the virus after the complete vaccination of the individual.

Abbreviation : 1. Chief Executive Officer

1 thought on “Pfizer’s COVID–19 vaccine update”

  1. Pingback: Covishield: The Covid vaccine of Serum Institute of India > PharmaCampus

Leave a Comment

Your email address will not be published. Required fields are marked *

Scroll to Top